FEDERAL CITY STRATEGIES for DAVITA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Healthcare reimbursement policy. H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015. Medicare payment for End Stage Renal Disease (ESRD). Education related to the issue that ESRD patients have access to Medicare Advantage plans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Health Issues HCR
Healthcare reimbursement policy. H.R. 1130, Chronic Kidney Disease Improvement in Research and Treatment Act of 2015. Medicare payment for End Stage Renal Disease (ESRD). Education related to the issue that ESRD patients have access to Medicare Advantage plans. Work on potential legislation to support better integration of care for ESRD patients.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Veterans VET
Issues related to Veterans access to dialysis services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.